CHIEF EDITOR
Brian Kent has participated in advisory boards and/or received speaker fees from Astra Zeneca, Chiesi, GSK, Novartis, and Teva; has received educational travel bursaries from Boehringer Ingelheim, Chiesi, and Napp; and has received research funding from Itamar Medical.
DEPUTY CHIEF EDITOR
Jayesh Mahendra Bhatt is a PI on studies sponsored by AstraZeneca and Boehringer Ingelheim; he has no personal (financial) interests in any pharmaceutical companies.
EDITORIAL BOARD
ERS Education Council, ERS Assembly Secretaries
Hilary Pinnock is a principal investigator on research grants in applied respiratory research from a number of national and international funders (e.g. National Institute for Health and Care Research; Medical Research Council; Global Alliance for Chronic Diseases). These fund programmes of work on supported asthma self-management, implementation of digital respiratory health, delivery of pulmonary rehabilitation in low- and middle- income countries, non-communicable disease prevention. All grants are paid to her University and she does not stand to gain financially from this work. In the past three years she has received funding for speaking at sponsored symposia on topics related to delivery of respiratory care from Novartis and Sandoz.
Frits M.E. Franssen has received grants (to his institution) from AstraZeneca, consulting fees from AstraZeneca, Chiesi and GSK, and payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from AstraZeneca, Boehringer Ingelheim, Chiesi and Novartis.
João Carlos Winck has received payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from Armstrong Medical, Philips, Breas and Nippon Gases; and support for attending meetings and/or travel from Vitalaire.
Niki Reynaert has received consortia grants for research from the Dutch Lung Foundation and has patents planned, issued or pending (Detection of glutathionylated proteins, U.S. Pat. Apl. Ser. No.: 11/698,300; Treatments Involving Glutaredoxins and Similar Agents, U.S. Pat. Apl. Ser. No.: 60/934,129; Detection of nitrosylated proteins, US publication number 2005-02874, International publication number WO2005/101019).
Esther Irene Schwarz has received research grants from Philips Respironics, Löwenstein Medical, Swiss National Science Foundation, and Lunge Zürich.
Florence Schleich has received grant support from AstraZeneca and GSK; honoraria and consultation fees from GSK, AstraZeneca, Chiesi, Sanofi, TEVA and ALK; support for attending meetings and/or travel from AstraZeneca and Chiesi; and has a patent planned, issued or pending: 15/761,520 method for the diagnosis of airway disease inflammatory subtype.
Rafael E. de la Hoz has received grants from the National Institute for Occupational Safety and Health, USA, and a non-promotional lecture honorarium from Teva, Denmark. He is secretary of ERS Assembly 6.
Refika Hamutcu Ersu has received grants from Children’s Hospital of Eastern Ontario Research Institute and reports a leadership role as the American Thoracic Society Sleep and Neurobiology Assembly Web committee co-chair.
Marcello Migliore has no potential conflicts of interest to disclose.
Jellien Makonga-Braaksma has no potential conflicts of interest to disclose.
Onno W. Akkerman has received grants from stichting Noord Nederland Beatrixoord.
Najib M. Rahman has received consultancy fees from Rocket Medical UK, BD Medical USA, Cook Medical and LTI USA.
Michael Kreuter reports grants and fees, to him or his institution, from Roche and Boehringer; personal fees from AstraZeneca, GlaxoSmithKlne, Galapagos and Chiesi.
Olivier Sitbon has received grants or contracts (payment made to his institution) from Janssen (formerly Actelion), Bayer, MSD and GSK; consulting fees from Janssen (formerly Actelion), MSD, Acceleron, Gossamer Bio and Bayer; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Janssen (formerly Actelion), Bayer, MSD, Ferrer, AOP Orphan and GSK; support for attending meetings and/or travel from Janssen (formerly Actelion) and Bayer; payment for participation on a Data Safety Monitoring Board or Advisory Board from Janssen (formerly Actelion), Gossamer Bio, MSD and Acceleron; and medical writing support from Janssen (formerly Actelion).
E. Magdalena Grabczak has received a grant from Polish National Science Centre for study on pathophysiological mechanisms during therapeutic thoracentesis.
Stelios Loukides reports payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from Chiesi Hellas, Astra Zeneka, GSK, Menarini, Guidoti, ELPEN, Sanofi and Pfizer; support for attending meetings and/or travel from Gilead, Pfizer, Chiesi and ELPEN; and is President of the Hellenic Thoracic Society.
Kjeld Hansen has received personal fees from GlaxoSmithKline (speaker reimbursement, Boehringer Ingelheim (consultancy fee), and AstraZeneca (consultancy fee).
Section Editors
Pierantonio Laveneziana has received personal fees from Novartis France and from Boehringer France.
Alexander G. Mathioudakis has received grants from Boehringer Ingelheim,
Associate Editors
Marco Clari has no potential conflicts of interest to disclose.
Gráinne d’Ancona has received fees for teaching or advisory board participation from AstraZeneca and Sanofi; funding to attend conferences from AstraZeneca and Sanofi; and Medical Education Goods and Services (MEGS) grants from AstraZeneca, Chiesi and GSK.
Stefano Elia has no potential conflicts of interest to disclose.
Georgios Kaltsakas has no potential conflicts of interest to disclose.
Julie M. Marchant receives royalty payments from Up-to-Date.
Cormac McCarthy has received grants and speaker fees from Boehringer Ingelheim, and speaker fees from Roche Ltd. He is on the scientific advisory boards of the LAM Foundation and the European Pulmonary Fibrosis Federation. He has a consulting contract with Savara Pharmaceuticals as part of their clinical advisory board.
Paola Pierucci has no potential conflicts of interest to disclose.
Andrew Prayle has received grants or contracts from Action for A-T, MRC Confidence in Concept, Nottingham University Hospitals Charity, Sir Jules Thorn Trust, and Academy of Medical Sciences; received travel and accommodation costs from Vertex Pharmaceuticals to support attendance at CF Exceed, Vienna 2022; and serves on the Action for A-T Research Advisory Committee (unpaid).
Silke Ryan has no potential conflicts of interest to disclose.
Imran Sulaiman has no potential conflicts of interest to disclose.
Early Career Member Committee representatives
Sara Cuevas Ocaña received an award from Action for Pulmonary fibrosis to support attendance at the ERS Congress 2022.
Heleen Demeyer has no potential conflicts of interest to disclose.
Maria Joana Catarata has received support for attending meetings and/or travel from Vivisol, Gasoxmed, Vitalaire and Medinfar.
Howraman Meteran has received payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from ALK-Abelló Nordic A/S, GSK Denmark, Novartis, AstraZeneca and Sanofi-Aventis Denmark (all payments made to institution); and has participated on a Data Safety Monitoring Board or Advisory Board for ALK-Abelló, GSK, Novartis and Teva. H. Meteran is a Current Board member of Danish Association for Clinical Nutrition, and a Former board member of Foreningen af Yngre Lungemedicinere (Danish Association for Young Respiratory Physicians).
Augusta Beech has no potential conflicts of interest to disclose.
This page was updated on 20 March 2024